IntegraGen announces the CE marking of its cloud-hosted online software application, MERCURY™ for interpreting molecular data tumors. This CE mark reinforces IntegraGen's ability to sell MERCURY within the European Union (EU) and in countries recognizing the CE mark. MERCURY is used by clinicians and researchers alike, enabling comprehensive analysis of large-scale high-throughput sequencing data, from exploration of small gene panels to extensive exome, transcriptome or whole-genome analysis.
MERCURY's CE-IVD mark guarantees that it meets the requirements of Directive 98/79/EC of the European Parliament and of the Council of October 27, 1998 on in vitro diagnostic devices. Click here to view MERCURY's CE declaration of conformity.
The cloud hosting provider used by MERCURY is regularly checked by independent auditors for security, confidentiality and compliance with international standards. Find out more on how IntegraGen ensures the security and confidentiality of genomic data.
April 13, 2020
Share :
Leave a Reply